[The surgeon and the metastatic disease]

Area of Science:

• Oncology
• Surgical Oncology
• Cancer Metastasis

Background:

• Historically, surgical intervention for metastatic disease was limited.
• Advancements in chemotherapy and targeted therapies in the late 20th century expanded surgical options.
• Surgeons now treat metastases in organs like the liver, lungs, peritoneum, and brain.

Discussion:

• Chemotherapy's efficacy allows for surgical removal of residual metastatic disease.
• Post-systemic therapy surgery may enhance progression-free survival.
• Overall survival benefits from this approach are still under investigation.

Key Insights:

• Metastatic disease management has evolved from a surgical "no-go" zone to a treatable condition.
• Synergistic effects between systemic therapies and surgery are crucial.
• Multidisciplinary strategies are key to optimizing outcomes for metastatic cancers.

Outlook:

• Emerging technologies are expected to further enhance surgical capabilities in treating metastatic disease.
• The expansion of surgical "therapeutic perimeters" is anticipated.
• Continued research into optimizing the integration of surgery and systemic treatments is essential.